Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator

Abstract

Stereotactic aspiration can be performed safely and in a relatively uniform manner; it leads to a modest reduction of 18 mL of hematoma reduction over 7 days when compared with control, which has a 7-mL reduction, and therefore may improve prognosis.